Despite recent efforts to reduce cardiovascular disease risk by dietary intervention, 1 few markers are useful to assess the efficiency and progress of this. Circulating levels of trimethylamine N-oxide (TMAO) are associated with poor outcomes of cardiovascular disease. [2] [3] [4] [5] [6] TMAO is generated via hepatic flavin monooxygenase 3 (FMO3) mediated oxidation of trimethylamine (TMA), 7 derived largely from carnitine and choline through gut microbial metabolism. These substrates are found in red meat and eggs, which are representative of a Western diet. Therefore, TMAO levels could be used to monitor the effect of dietary intervention, particularly for the consumption of a Western diet. In this study, we examined the effect of acute choline loading on TMAO levels in healthy adult volunteers.
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Eighteen healthy omnivorous adult volunteers, with no history of recent use of antibiotics/probiotics, completed this study. Baseline characteristics and blood samples were obtained from participants at baseline. Participants were asked to complete a daily written food diary and returned after two weeks (visit 2 (V2)). The consumption of red meat, fish and eggs was not permitted 24 h before baseline and V2. Prior to taking 700mg of choline bitartrate (Solgar, USA) and microcrystalline cellulose capsules, a blood sample was collected to measure TMAO level at time zero (0), then at 2, 4, 6 and 8 h post choline consumption. During V2, participants were given a standardised low-choline breakfast and lunch (total choline intake <50 mg), 8 between 0-2 and 4-6 h respectively. This protocol was approved by the local ethics committee and adhered to the Declaration of Helsinki. All participants provided written informed consent. Plasma samples were quantified in duplicate for TMAO, using stable isotope dilution liquid chromatography-tandem mass spectrometry on a Shimadzu LC-30AD coupled with an 8050 triple quadruple mass spectrometer (TQ-MS), using an optimised version of a previously described method, 9 with a run time of 1 min and limit of quantification of 0.1 mmol/L. Individual responses of circulating TMAO levels in participants are shown in Figure 1 (a).
Participants showed a range in circulating TMAO levels of 0-20 mmol/L over the 8-h period, with a few (n ¼ 4) showing higher TMAO levels following 6 h postcholine consumption (>20 mmol/L). We observed that there were patients that showed raised TMAO levels in response to choline loading ('responders') and those that did not ('non-responders'). To further investigate the different responses to choline loading (response vs. non-response), participants were split according to the median baseline TMAO level of 2.0 mmol/L (Figure 1 (b)) into high TMAO (HT) and low TMAO (LT) groups. TMAO levels rapidly and significantly increased from 4 h after choline loading in the HT group; in contrast, TMAO levels showed no change at any time point after choline loading in the LT group (Figure 1 (b)) (p ¼ 0.012). TMAO levels in the HT group were higher than those in the LT group at all times during the acute oral choline challenge (3.1-16.3 mmol/L vs. 1.3-3.3 mmol/L, respectively). Participants in the HT group (n ¼ 9) tended to be older and had higher alcohol intake compared with those in the LT group (n ¼ 9); however, this was not statistically significant (p ¼ 0.094 and p ¼ 0.063, respectively). Gender, ethnicity, body mass index and weekly physical activity were similar between groups (p > 0.05). Dietary records from the two weeks prior to acute choline loading as well as baseline records did not show any differences in TMA rich food intake (red meat, eggs or fish) between groups (Table 1) . No side effects (e.g. fishy body odour) were reported during the study. The present study indicates that acute choline loading in healthy subjects produces a differential response in circulating TMAO levels (i.e. 'responders' and 'non-responders'). These two different response groups in TMAO production following choline challenge were demonstrated for the first time by the present study. To note, individuals with a 'responder' phenotype had higher baseline TMAO levels. Furthermore, food diaries from these individuals, assessed to determine protein intake in the two weeks before choline loading, showed no significant differences in TMA rich foods (e.g. red meat, eggs) compared with those with a 'non-responder' phenotype. This indicates that omnivorous individuals can have different responses to dietary sources of choline, independently of daily dietary conditions. TMAO levels were also analysed for association with participants' physical activity due to the beneficial effect of physical activity on cardiovascular risk, in particular when combined with dietary intervention. 10 We did not observe differences in TMAO levels with respect to physical activity between the low and high TMAO groups. In previous studies, acute dietary supplementation of choline has been shown to increase TMAO levels in a general population. 11 However, most studies have focused on carnitine, demonstrating the effect of L-carnitine supplementation with increased TMAO levels correlated to chronic carnitine intake. 12 TMAO levels have been attributed more to carnitine rather than choline and from red meat rather than other sources of protein. 13 Whilst these studies showed that TMAO levels are significantly increased with L-carnitine and red meat intake, they did not account for baseline differences in the TMAO levels of participants and whether these could affect subsequent TMAO increase, underlying a responder or non-responder phenotype. Further, single TMAO time point cross-sectional studies are unable to ascertain whether there are temporal or individual differences in TMAO production, following dietary/loading challenge (e.g. response). The current study sheds light upon the hypothesis that individuals respond differently to dietary choline intake, which could be related to reduced FMO3 activity or gut bacterial conversion of choline to TMA, resulting in inefficient conversion of choline to TMAO. Further investigation of gut microbial composition and FMO3 activity to identify outstanding factors for response to choline loading is warranted.
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